Grace Therapeutics, Inc

GRCENASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

16.3M

on 2026-06-30, from 9.40M on 2024-03-31 10-Q ↗

Newest

None

No S-3 or F-3 shelf on file in the last 30 months.

2 of its filings are not read yet.

Warrants

None

Priced warrants: none left. 10-K ↗

Cash

5.3 quarters

$13.8M on 2026-06-30 ÷ $2.6M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised: 4 of its filings are not read yet.